Health Care/Hospital

Sam Ngoc Linh Kon Tum K5 has officially launched beauty and health products for men and women

KON TUM, Vietnam, Dec. 8, 2020 /PRNewswire/ -- The representatives of Sam Ngoc Linh Kon Tum K5 has just launched two beauty health products, including Love For Men's Health - a physiological enhancer for men's health; Love For Women's Health - supports the improvement of female hormones, premenop...

2020-12-08 13:00 1959

Cigna Global Employer Health Partners with InterNations to Offer a Scholastic Solution for Students, Chaperones and Faculty Participating in a Study Abroad Program

The new, flexible Cigna StudyWell™ offering makes it simple, predictable and affordable for populations studying abroad to access whole person health care.    BLOOMFIELD, Conn., Dec. 8, 2020 /PRNewswire/ -- Cigna Global Employer Health (CGEH) Americas, a division of global health service company...

2020-12-08 11:58 4461

Willis Towers Watson's Survey Expects Medical Costs in Indonesia to Increase up to 12% in 2021

JAKARTA, Indonesia, Dec. 8, 2020 /PRNewswire/ -- Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, announced it expects medical costs inIndonesia to increase up to 12%. Willis Towers Watson announced the findings following an in-depth report which cite...

2020-12-08 11:37 6494

China Renaissance Congratulates JD Health on its Landmark Hong Kong IPO

HONG KONG, Dec. 8, 2020 /PRNewswire/ -- China Renaissance ("China Renaissance", stock code: 1911.HK) congratulatesJD Health International Inc. ("JD Health" or the "Company", stock code: 6618.HK) on its landmark initial public offering ("IPO") on the Hong Kong Stock Exchange, which raised approxim...

2020-12-08 11:12 6274

TUV Rheinland certifies respirators

COLOGNE, Germany, Dec. 8, 2020 /PRNewswire/ -- TUV Rheinland InterCert is Notified Body for the certification of particle-filtering masks. Manufacturers can now have their products, also known as respirators, tested and certified in the laboratories of TUV Rheinland. For certification by the inte...

2020-12-08 09:41 1539

Ascentage Pharma Announces Positive Data from Pivotal Phase II Studies of HQP1351 (Olverembatinib) in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) at 2020 American Society of Hematology (ASH) Annual Meeting

SUZHOU, China, and ROCKVILLE, MD, Dec. 8, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today reported positive data from two pivotal...

2020-12-08 08:16 2115

Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

SAN FRANCISCO and SUZHOU, China, Dec. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...

2020-12-08 08:00 4341

A­­­­­izon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies to Achieve Smart and Continuous Manufacturing

Aizon accelerates pharma manufacturing by bolstering the client's currently deployed technology with AI and ML capabilities to boost production performance SANTA CLARA, Calif., Dec. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the North American artificial intelligence (AI) market for ...

2020-12-08 01:57 1466

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

SAN FRANCISCO, Dec. 7, 2020 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today announced a strategic partnership with Pfizer Inc. (NYSE: PFE) with the goal of accelerating small molecule drug discovery by developing a ...

2020-12-07 22:37 3500

Through Strategic Collaboration with GenScript ProBio, Initium Therapeutics Plans to Utilize GenScript ProBio's Berkeley Lights Beacon Platform to Expand Their Antibody Drug Pipeline

NANJING, China, Dec. 7, 2020 /PRNewswire/ -- On December 7, 2020, GenScript ProBio and Initium Therapeutics announced that Initium Therapeutics has launched a single B-cell based antibody development platform through collaboration with GenScript ProBio. Initium Therapeutics is a US biotechnology ...

2020-12-07 22:00 1452

Happiness Biotech Provides Sales Update: E-Commerce Business of Over $3 million Since November

NANPING, China, Dec. 7, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company's wholly-owned subsidiary focusing on e-commerce business, has recorde...

2020-12-07 22:00 3740

Chaim Lotan, MD announces the official launch of DiNovA's Israel Incubator at ICI

TEL AVIV, Israel, Dec. 7, 2020 /PRNewswire/ -- December 7th, 2020, Chaim Lotan, MD announced the official launch of DiNovA Israel Incubator at the DiNovA Session of ICI (Innovations in Cardiovascular Interventions) 2020 Global Digital Summit. Earlier this year in April, Hangzhou Dinova Ruihua Me...

2020-12-07 21:50 2028

Global Cord Blood Corporation Announces Results of 2020 Annual General Meeting

HONG KONG, Dec. 7, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2020 Annual Ge...

2020-12-07 21:30 7894

PharmAbcine to present new interim data from its ongoing mTNBC trial at SABCS 2020

DAEJEON, South Korea, Dec. 7, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will present the updated interim data from the ongoing phase Ib trial of olin...

2020-12-07 21:00 1093

Merck Expands Life Science Production Capacities in the United States

-- Expansions to significantly increase capacity by end of 2021 to meet unprecedented demand -- Combined expansion of Danvers, Massachusetts, and Jaffrey, New Hampshire, USA facilities to create nearly 700 new positions -- Business sector's announced 2020 investments total more than € 350 millio...

2020-12-07 21:00 2055

INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced it has dosed its first subject in a Phase 2 clinical tr...

2020-12-07 21:00 3351

JW Therapeutics Presents Data from Pivotal Trial of Relma-cel at the 62nd ASH Annual Meeting

SHANGHAI, Dec. 7, 2020 /PRNewswire/ -- JW Therapeutics (stock code: 2126.HK), a leading clinical stage cell therapy company, presented data from the pivotal study (RELIANCE Trial) of relmacabtagene autoleucel ("relma-cel") under IND pathway at the 62nd American Society of Hematology (ASH) Annual ...

2020-12-07 18:30 2156

The Mullings Group Opens London Office To Service Talent Acquisitions for Growing MedTech Clientele in U.K., EU and Middle East

LONDON, Dec. 7, 2020 /PRNewswire/ -- The Mullings Group, a leading talent acquisition firm in the U.S. specializing in medical & health technology and life sciences, has opened an office inLondon to service the growing needs of its clientele in the U.K., E.U. and theMiddle East. "We experienced ...

2020-12-07 15:00 1185

GEN inCode Appoints Chief Financial Officer

OXFORD, England, Dec. 7, 2020 /PRNewswire/ -- GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease announces today the appointment of Paul Foulger as Chief Financial Officer to the Company. Paul Foulge...

2020-12-07 15:00 1267

YES Partners with Singapore's Gaia Science

FREMONT, Calif., Dec. 7, 2020 /PRNewswire/ -- YES (Yield Engineering Systems, Inc.), a leading manufacturer of process equipment for semiconductor advanced packaging, Life Science and "More-than-Moore" applications, today announced that it has signed an agreement with Gaia Science Pte. Ltd ofSing...

2020-12-07 09:00 1847
1 ... 585586587588589590591 ... 807